Back to Search
PETER WEISSMAN, MD
MD
Specialist
NPI: 1841274529Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
ME18664(FL)
Research & Publications (7)
Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study.
PMID 16368054·Curr Med Res Opin·2005
4-observational
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
PMID 12231078·Am J Cardiol·2002
6-review
Clinical practice effect of rosiglitazone discontinuation on glycemic control.
PMID 19364698·Endocr Pract·2009
8-other
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.
PMID 16968575·Curr Med Res Opin·2006
3-trial
Expansion of a lung abscess after stent closure of a bronchoesophageal fistula.
PMID 11818943·Gastrointest Endosc·2002
5-case
Rapid collisional evolution of comets during the formation of the Oort cloud.
PMID 11214311·Nature·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7867 N KENDALL DR, SUITE 80
MIAMI, FL 33156 - Phone
- (305) 595-0777
Quick Facts
- NPI
- 1841274529
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile